Participated · Series C · Jan 2026

Founded in 2022 and headquartered in Brisbane, CA, Mytra develops an operating system that abstracts material flow into programmable primitives—move, store, pick, and route—enabling flexible, software-defined automation for warehouses and factories. The platform targets the 80% of industrial sites that currently have no automation by reducing cost and complexity while reclaiming aisle and clearance space; early deployments have cut material-handling labor by 32% and improved storage density by 34%. In 2025 the company secured contracts with a Fortune 100 food company and a Fortune 500 industrial-supply distributor, including one deployment 60× larger than any previous installation. Operational momentum included shipping two pilot systems, bringing a new facility seven times larger than its prior space online, and expanding headcount by 78% while adding senior executives such as a CFO, Chief Development Officer, and VP of Scaling. Former Tesla CFO Zach Kirkhorn also joined the board. Mytra is currently hiring for more than 20 roles to support rising demand. The company has raised more than $200 million to date to finance rapid scaling of its software-defined automation platform.

Led · Series A · Jun 2025

HOPPR offers a purpose-built platform for developers and PACS vendors to fine-tune and deploy foundation models for medical imaging with secure tooling, curated datasets, and traceable data provenance. The platform emphasizes quality management, secure development pipelines, and support for marketing authorization to help move models from concept to clinical deployment. HOPPR enables users to use their own data or HOPPR’s expertly curated datasets to develop high-performing, clinically ready AI applications. The company positions itself as an alternative to marketplaces by focusing on model refinement, validation, and clinical readiness rather than prebuilt apps. With an oversubscribed Series A, HOPPR plans to accelerate platform development, scale operations, expand its foundation model capabilities, and grow its engineering, AI, and compliance teams. The company frames these efforts as enabling improved diagnostic workflows and better patient care globally.

Participated · Series B · Apr 2025

Plenful provides a purpose-built AI workflow automation platform that handles messy, disparate workflows across formats, systems, and departments to reduce errors and streamline healthcare operations. Its most adopted use cases include prior authorization, 340B compliance and missed opportunity auditing, and order and referral data entry. The platform offers real-time reporting and task management and is used by pharmacies, health systems, provider groups, and payors. Plenful reports over 4x year-over-year growth and is trusted by more than 60 leading U.S. healthcare organizations. Customers cite significant efficiency gains—one customer reported a 96% reduction in time spent on a workflow—allowing redeployment of staff to higher-value tasks. With this traction, the company plans to expand its platform to address additional unmet needs across pharmacy, health systems, provider groups, and payor markets. Plenful intends to invest in machine learning, engineering, product, partnerships, and customer success as it scales. Plenful is an AI workflow automation platform that streamlines pharmacy and healthcare operations with a highly-configurable software suite. It automates administrative tasks for health system, specialty, long-term care, compounding pharmacies and specialty providers. The platform claims to reduce manual work by up to 97% and to automate more than 95% of document data entry, while identifying millions of dollars in savings opportunities. Core use-cases include 340B auditing and missed-opportunity identification, contracted rates and inventory optimization, and intelligent document data-entry automation. Customers named in the article include Tampa General Hospital, Renown Health, Salinas Valley Health, Blue Cross Blue Shield, and dozens of other healthcare teams. Plenful plans to build out infrastructure, tailor automations to customer needs, and expand its machine-learning capabilities with a focus on LLMs to improve the customer experience. The company announced a $17M Series A, bringing total capital raised to more than $25M. Plenful offers a no-code, highly configurable workflow automation platform designed for healthcare providers and pharmacies to automate administrative work and reduce manual data entry. The platform sits on top of disparate data sources, ingesting PDFs and electronic medical records, validating data and applying algorithms to surface actionable insights and prevent errors. Customers use the product to automate document data entry for onboarding and referring prescription orders, perform audits, and identify potential areas of savings. Plenful was founded during the pandemic and is positioned to reduce technician burnout by freeing clinical teams to focus on top-of-license activities. The company has a roughly 20-person team, about 20 healthcare customers, and reports multiple years of runway. Planned use of funds includes building out the platform and expanding engineering, product, sales, and operations headcount while scaling the customer base.